SWM
APYX icon

Spire Wealth Management’s Apyx Medical APYX Stock Holding History

Spire Wealth Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,000
Closed -$13K – 2516
2021
Q4 		$13K Buy
+1,000
New +$14K ﹤0.01% 2265
2021
Q2 		– Sell
-1,000
Closed -$10K – 2581
2021
Q1 		$10K Buy
+1,000
New +$10K ﹤0.01% 2402

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Spire Wealth Management's APYX Position: Q1 2022 in Review

Spire Wealth Management sold out of Apyx Medical (APYX) in Q1 2022, closing a stake of 1,000 shares — an estimated $13K sold.

Spire Wealth Management first reported a position in APYX in Q1 2021 and held it in 2 quarters. The position peaked at $13K in Q4 2021. 71 funds tracked by Wall St. Rank hold APYX as of Q1 2022.

  • Spire Wealth Management reported no remaining Apyx Medical position as of Q1 2022 after selling out during the quarter.
  • Spire Wealth Management sold 1,000 Apyx Medical shares in Q1 2022, an estimated $13K.
  • Spire Wealth Management first reported a position in Apyx Medical in Q1 2021 and held it in 2 quarters.
  • Spire Wealth Management's Apyx Medical position peaked at $13K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2022.

Based on Spire Wealth Management's 13F filing for Q1 2022, filed 18 Apr 2022.